To explore the possibility that vitamin D status regulates sulfate homeostasis, plasma sulfate levels, renal sulfate excretion, and the expression of the renal Na-SO4 cotransporter were evaluated in vitamin D-deficient (D-D-) rats and in D-D-rats rendered normocalcemic by either vitamin D or calcium/lactose supplementation. D-D-rats had significantly lower plasma sulfate levels than control animals (0.93+/-0.01 and 1.15+/-0.05 mM, respectively, P &lt; 0.05), and fractional sulfate renal excretion was approximately threefold higher comparing D-D-and control rats. A decrease in renal cortical brush border membrane Na-SO4 cotransport activity, associated with a parallel decrease in both renal Na-SO4 cotransport protein and mRNA content (78+/-3 and 73+/-3% decreases, respectively, compared with control values), was also observed in D-D-rats. Vitamin D supplementation resulted in a return to normal of plasma sulfate, fractional sulfate excretion, and both renal Na-SO4 cotransport mRNA and protein. In contrast, renal sulfate excretion and renal Na-SO4 cotransport activity, protein abundance, and mRNA remained decreased in vitamin D-depleted rats fed a diet supplemented with lactose and calcium, despite that these rats were normocalcemic, and had significantly lower levels of parathyroid hormone and 25(OH)-and 1,25(OH)2-vitamin D levels than the vitamin D-supplemented groups. These results demonstrate that vitamin D modulates renal Na-SO4 sulfate cotransport and sulfate homeostasis. The ability of vitamin D status to regulate Na-SO4 cotransport appears to be a direct effect, and is not mediated by the effects of vitamin D on plasma calcium or parathyroid hormone levels. Because sulfate is required for synthesis of essential matrix components, abnormal sulfate metabolism in vitamin D-deficient animals may contribute to producing some of the abnormalities observed in rickets and osteomalacia. 
Introduction
Sulfate, the fourth most abundant anion in human plasma, is known to play an essential role in a variety of biochemical processes. Despite its potential importance, sulfate levels are almost never measured in clinical practice, little is known about the factors that regulate sulfate homeostasis in mammals, and the possible contribution of abnormalities in the regulation of sulfate metabolism to the pathogenesis of human diseases is largely unexplored (1) .
Sulfated proteoglycans constitute the largest group of sulfoconjugates in mammals, and it is well established that these proteoglycans are required for the maintenance of normal structure and function of bone and cartilage (2, 3) . Thus, it is reasonable to postulate that diseases affecting sulfate metabolism may be likely to result in abnormalities in cartilage and/or bone. In support of this hypothesis, genetic defects involving a sulfate transport protein (DTDST) 1 have been shown recently to be responsible for three different types of osteochondrodysplasia, diastrophic dysplasia, type IB achondrogenesis, and type II atelosteogenesis (4) (5) (6) . In these osteochondrodysplasias, undersulfation of cartilage proteoglycans is associated with abnormalities affecting the organization of collagen fibrils, the tinctorial properties of proteoglycans, and the number and morphology of chondrocytes. The severity of the phenotype appears to be correlated with the predicted effect of the mutations on the residual activity of the DTDST protein (6) . Similarly, a defect in the conversion of adenosine 5 Ј -phosphosulfate to 3 Ј -phosphoadenosine 5 Ј -phosphosulfate produces brachymorphism in mice, a disorder characterized by short stature and associated with the production of undersulfated proteoglycans (7) .
Several considerations raise the possibility that certain of the skeletal abnormalities seen in vitamin D deficiency could result from abnormal sulfate metabolism. First, several pathological features seen in 1,25(OH) 2 D deficiency states are not easily explained solely by changes in calcium and phosphate metabolism. Thus, although hypocalcemia and hypophosphatemia easily account for the impairment in mineral deposition typical of rickets and osteomalacia (8) , the disorganization of the chondrocyte columns seen in rachitic cartilage and the presence of abnormalities in the maturation of chondrocytes (8, 9) are more difficult to attribute to this mechanism. Furthermore, changes in the physical properties of proteoglycan aggregates in rachitic rat bone (10) and a reduction in sulfate fixation in the matrix of growth plate cartilage in vitamin D-deficient rats have also been reported (11) , findings that are consistent with the presence of abnormalities of sulfate metabolism in 1,25(OH) 2 D deficiency. Finally, the intestine and kidney, two of the principal target organs for 1,25(OH) 2 D action, are also known to represent the two most important tissues implicated in the regulation of extracellular concentrations of inorganic sulfate (12) . Nevertheless, no direct evidence for abnormalities in the circulating levels of sulfate in vitamin D-deficient animals has been reported.
The aim of this study was to investigate the effects of vitamin D status on sulfate homeostasis. In view of the striking reduction in extracellular sulfate levels observed in vitamin D-deficient animals, the mechanisms responsible were further investigated. First, the effect of vitamin D deficiency on renal sulfate excretion and expression of the recently described renal Na-SO 4 cotransporter (13) was evaluated. Second, we sought to determine whether vitamin D deficiency per se played a direct role in the regulation of sulfate homeostasis, or whether the calcium deficiency and/or elevated circulating PTH levels produced by vitamin D deficiency were causative factors in this model.
Methods
Animals and diet. The animals were divided into four groups as reported (14) . Briefly, a group of rats maintained on standard laboratory chow containing 0.75% calcium, 0.66% phosphate, and 2,000 IU/kg vitamin D for 6 wk served as controls (control or D 
Ca
ϩ group). Vitamin D-deficient diets supplemented with high calcium and lactose have been used previously to maintain normocalcemia in vitamin D-deficient rats (15, 16) . In all cases, protein was given in the form of casein, and the amount of inorganic sulfate in the diets was similar. Animals were killed at 6 wk after being anesthetized by intraperitoneal injection of phenobarbital. Plasma biochemical parameters for the animals studied here have been reported previously (14) and are summarized in Table I . For the study of the renal Na-SO 4 cotransporter, the kidneys were rapidly excised, immersed in liquid nitrogen, and stored at Ϫ 80 Њ C.
Measurement of plasma sulfate by capillary electrophoresis. Inorganic plasma sulfate and phosphate concentrations were determined by capillary electrophoresis using a P/ACE 2100 apparatus (Beckman Instruments, Inc., Fullerton, CA) equipped with a UV detector and 254 nm filter (17) (18) (19) (20) . Absorbance was continuously monitored using a 20 Hz sampling rate with a 0.1-s time constant, and the area under the peaks corresponding to the migration of sulfate, corrected for the elution rate, was determined.
For each experiment, standard curves relating sample concentration to corrected peak area were generated using at least six different concentrations of the standard solutions. Regression analysis demonstrated that these standard curves were linear over the range of concentrations studied (0.05-1 mM) with correlation coefficients Ͼ 0.998. Each plasma sample was analyzed at two dilutions (1/4 and 1/8) in pure bi-distilled water, and three aliquots (8 nl each) of each dilution were assayed. For each aliquot, sulfate concentrations were determined by interpolation from the standard curve, and the six values were averaged.
RNA extraction. Total RNA from kidney was extracted as described (14) using the guanidinium thiocyanate/cesium chloride method. RNA concentrations were determined by absorbance at 260 nm, and the integrity of the RNA species was evaluated by electrophoresis into 1% agarose gels containing ethidium bromide. RNA preparations were stored at Ϫ 80 Њ C until analysis.
Probes and ribonuclease (RNase) protection assays. To produce a plasmid from which Na-SO 4 cotransporter riboprobe could be transcribed, cDNA from rat kidney was used as template to amplify by PCR a 266-bp fragment of the cDNA coding for the Na-SO 4 cotransporter using the oligonucleotides 5 Ј -GTAGCAAGGAAGCAGAA-TGT (upper primer) and 5 Ј -ATTCACCCCCACCATCATCA (lower primer). The 266-bp fragment (corresponding to nucleotides 109-375 in the sequence published by Markovitch et al. [13] ) was cloned into the pCR II vector (TA cloning kit; Invitrogen, San Diego, CA). The vector was linearized with SpeI and a 373-bp radiolabeled antisense RNA probe was generated by in vitro transcription using T7 polymerase and [ 32 P]UTP. After hybridization with sample RNA and digestion with RNases, this riboprobe produced a specific protected fragment of 266 bp. A previously described construct containing a fragment of the cDNA coding for GAPDH cloned into Bluescript II SK ϩ was used to synthesize a GAPDH riboprobe of 192 bp that produced a specific protected fragment of 164 bp in the RNase protection assay (14) .
To perform the RNase protection assays, 10 g of total RNA extracted from the kidney of each animal was hybridized with 5 ϫ 10 5 cpm Na-SO 4 riboprobe and 5 ϫ 10 4 cpm GAPDH riboprobe overnight at 50 Њ C (14) . The radioactivity present in the bands corresponding to the protected fragments of the Na-SO 4 transporter and GAPDH riboprobes was quantified by electronic autoradiography (InstantImager; Packard Instruments, Meriden, CT). RNase protection analysis was performed in duplicate on samples from 6-10 animals in each group. For each sample, the Na-SO 4 transporter mRNA/ GAPDH mRNA ratio was calculated. The results obtained in the control group (D ϩ D ϩ ) were defined as 100%, and the results from the three other groups of animals are expressed as a percentage of the value obtained for control animals studied in the same experiment.
Preparation of brush border membranes (BBM). BBM from kidney cortices were prepared by a Mg 2 ϩ precipitation method, as described (21) . After the final centrifugation, BBM were resuspended in 10 mM Tris-HCl (pH 7.0) containing 50 mM mannitol (Western blots), or 10 mM Tris-HCl (pH 7.5) containing 300 mM mannitol (Na-SO 4 transport measurements). Protein was measured using the Coomassie protein assay reagent (Pierce Chemical Co., Rockford, IL) based on the Bradford method (22). Preparation of antibodies. Polyclonal antibodies against renal Na-SO 4 cotransporter NaSi-1 (13) were raised in rabbits by immunization with a fusion protein containing a 53-amino acid polypeptide derived from the Na-SO 4 cotransporter sequence. This antibody preparation specifically detected a 68-kD protein on Western blots of proteins isolated from renal BBM and specifically stained proximal tubular BBM in renal tissue evaluated using immunohistochemical techniques (23) . A second nonspecific band of apparent molecular mass of 70 kD was also detected with the antibody. As previously reported (23), the reactivity of the antibody with this band is not prevented in the presence of the antigenic fusion protein, and the expression of this band is not regulated.
Table I. Biochemical Parameters in the Four Groups of Rats
BBM protein electrophoresis and Western blots. Experiments were performed as described (24) . Briefly, BBM proteins were denatured in 95 mM Tris-HCl (pH 6.8) containing 2% SDS, 10% glycerol, 0.5 mM EDTA, and 100 mM dithiothreitol (final concentrations). 35 g BBM protein per lane was electrophoresed on 10% polyacrylamide gels according to Laemmli (25) , and the samples were electrotransferred onto nitrocellulose membranes. After blocking the membrane with Tris-buffered saline (pH 7.4) containing 5% skimmed dried milk and 1% Triton X-100, membranes were incubated overnight with a 1:5,000 dilution of the polyclonal antibody specific for the Na-SO 4 cotransporter NaSi-1. Antibody binding was detected by chemiluminescence using the ECL Western blotting protocol (Amersham Life Science, Buckinghamshire, UK) as described by the manufacturer, using a donkey anti-rabbit whole antibody linked to horseradish peroxidase. Signals recorded on x-ray film were quantified by densitometric scanning and peaks integrated using the Image Quant software package (Molecular Dynamics Inc., Sunnyvale, CA). Western blots were performed on BBM prepared from kidneys obtained from three rats in each group. Results are expressed relative to values obtained for the control rats (D ϩ D ϩ group) studied in each series of experiments. Equal loading was ensured by protein staining of gels run in parallel.
BBM Na-SO 4 transport measurements. Measurement of Na-SO 4 transport was performed on freshly isolated BBM vesicles using a procedure based on radioisotope uptake followed by rapid Millipore filtration, as described (26, 27) . Suspensions of BBM were equilibrated at room temperature for 1 h in preloading buffer (10 mM TrisHCl, pH 7.5, containing 300 mM mannitol). 30 g of BBM suspended in 10 l of preloading buffer was then mixed at room temperature with 40 l of extravesicular uptake buffer containing 50 Ci/ml H 2 [ 35 S]SO 4 (43 Ci/mg; ICN Biomedicals, Costa Mesa, CA) to produce solutions containing (final concentrations) 5 mM Tris-HCl (pH 7.5), 100 mM mannitol, and either 100 mM Na-gluconate (Na-dependent uptake) or 100 mM potassium gluconate (Na-independent uptake) in the presence of 0.05-5 mM K 2 [ 35 S]SO 4 . Uptake was terminated after 90 s by the addition of 2 ml of ice-cold stop solution (10 mM TrisHCl, pH 7.5, containing 300 mM mannitol, 2 mM CaCl 2 , and 1 mM HgCl 2 ) (28) and filtration of the suspension across a 0.45-m pore membrane (HAWP; Millipore Corp., Milford, MA). Filters were then washed four additional times with 2 ml stop solution, and radioactivity was counted. [ 35 S]SO 4 specific activity was determined experimentally for each series of measurements. Na-dependent SO 4 ( 43 Ci/mg; ICN Biomedicals) was suspended in 0.15 M NaCl and administered by intravenous infusion at a rate of 50 l/min per 100 g body wt until a total dose of 100 Ci/200 g body wt had been administered. Inulin and sulfate clearances were measured as previously reported (29, 30) .
Presentation of data and statistical analysis. Results are presented as meanϮSEM unless otherwise stated. Samples from the different groups of rats were evaluated simultaneously in all experiments. Statistical comparisons were performed by one-way ANOVA; comparisons between individual groups were made using the Fisher LSD test (31). Fractional sulfate excretion was expressed as a function of urinary output, and results were analyzed by comparing the regression lines obtained for the vitamin D-supplemented and the vitamin-deficient rats (31). P values Ͻ 0.05 were considered significant. 4 cotransporter mRNA expression. Because renal reabsorption of sulfate is important in maintaining plasma sulfate levels within a normal range, abnormalities in the expression of the renal Na-SO 4 transporter represent a possible cause of hyposulfatemia seen in vitamin D-deficient rats. To explore this possibility, mRNA coding for the Na-SO 4 cotransporter was measured in kidney from vitamin D-deficient and control animals using RNase protection analysis (Fig. 1) . In all experiments, the amount of Na-SO 4 cotransporter mRNA in kidney from the vitamin D-deficient rats (D Ϫ D Ϫ group) was found to be reduced compared with that obtained in kidneys from control animals (D ϩ D ϩ group). Overall, the ratio of counts per minute in the bands corresponding to the protected fragments of Na-SO 4 cotransporter mRNA and GAPDH mRNA was reduced by 73Ϯ3% compared with vitamin D-deficient and control animals ( Fig. 1 B, P Ͻ 0.05). As was observed for plasma sulfate levels, Na-SO 4 cotransporter mRNA levels were normal in vitamin D-deficient animals that received vitamin D supplementation for 1 wk before time of killing (95Ϯ8% of control values, Fig. 1 ). Similar changes were not observed for Na-PO 4 cotransporter type II mRNA (32) as previously reported in similar experimental conditions (33) (data not shown).
Results

Effects of vitamin
Na-SO 4 cotransporter protein abundance. To determine whether the reduction in mRNA coding for the Na-SO 4 cotransporter seen in vitamin D-deficient animals was associated with reduced expression of the cotransporter protein, BBM were isolated from kidney cortex, and Na-SO 4 cotransporter protein was measured by Western blotting. Vitamin D deficiency was associated with a 78Ϯ3% decrease in the abundance of the Na-SO 4 cotransport protein ( Fig. 2 , P Ͻ 0.05 comparing vitamin D-deficient animals and controls). Strikingly, vitamin D supplementation of previously vitamin D-deficient animals for 1 wk before time of killing led to an increase in Na-SO 4 cotransporter protein expression to levels similar to those observed in the control animals (Fig. 2, 78Ϯ16% . In contrast to Na-SO 4 cotransporter protein expression, no decrease in the Na-PO 4 cotransporter protein type II was seen when the same blots were probed with an antibody raised against a NH 2 -terminal peptide of the Na-PO 4 cotrans-porter type II (data not shown). The presence of a decreased Na-SO 4 cotransporter in absence of a decreased Na-PO 4 cotransporter underlines the fact that the changes in Na-SO 4 cotransporter are not one of multiple impairments of sodiumcoupled cotransporters in renal proximal tubules. BBM Na-SO 4 cotransport activity. In agreement with the decrease in Na-SO 4 cotransporter protein expression, vitamin D deficiency caused a significant decrease in BBM Na-SO 4 cotransport activity (Fig. 3) . Studies evaluating the kinetics of Na-dependent SO 4 cotransport as a function of extravesicular SO 4 concentration indicated that vitamin D deprivation caused a decrease in the V max of Na-SO 4 cotransport, without changing the affinity of the transporter for SO 4 (Fig. 3, inset) .
Effect of calcium supplementation on sulfate homeostasis in vitamin D-deficient rats
It was of interest to determine whether the hyposulfatemia and changes in renal Na-SO 4 cotransport as observed in vitamin D-deficient rats were a direct consequence of vitamin D deficiency, or whether secondary changes resulting from vitamin D deficiency, such as hypocalcemia and/or hyperparathyroidism, were more directly involved in producing the changes in sulfate metabolism. To evaluate this question, rats receiving a vitamin D-deficient diet that was supplemented with high calcium and lactose during the final week before time of killing were also studied. As expected, calcium/lactose supplementation (D Ϫ Ca ϩ group) produced an increase in plasma calcium to levels similar to those of control animals ( Table I) . Plasma PTH concentrations decreased substantially in these normocalcemic rats, whereas plasma 25(OH)D and 1,25(OH) 2 concentrations remained significantly lower than those of control rats ( Table I) . As was observed for calcium concentrations, plasma sulfate concentrations in the rats receiving lactose/calcium supplementation also increased to levels that were not significantly different from those of control animals (1.09Ϯ0.01 In contrast to the striking effect observed in response to vitamin D supplementation, however, treatment of vitamin D-deficient rats with calcium/lactose supplementation did not change renal Na-SO 4 cotransport. Thus, despite the normalization of plasma calcium and the marked decrease in plasma PTH levels observed in calcium/lactose-supplemented animals, renal Na-SO 4 cotransport steady state mRNA levels, protein abundance, and activity were reduced to a similar extent in the D (Table II) .
Effect of vitamin D status on urinary sulfate excretion
To directly evaluate whether the changes in renal Na-SO 4 cotransport activity observed in vitamin D-deficient animals resulted in changes in renal handling of sulfate, urinary sulfate excretion in vivo was evaluated in vitamin D-deficient and control rats. Glomerular filtration rates were not significantly modified by vitamin D status (0.48Ϯ0.04 vs. 0.58Ϯ0.09 ml/min per 100 g of body wt, meanϮSEM, respectively, in vitamin D-depleted [n ϭ 9] and vitamin D-repleted [n ϭ 6] rats, P Ͼ 0.2). As shown in Fig. 4 , the fractional excretion of sulfate in these animals varied as a function of urinary output. Importantly, for any given level of urinary output, fractional sulfate excretion was approximately threefold higher comparing vita- 2Ϫ per milligram of protein per 90 s. Kinetic parameters were calculated by nonlinear curve fitting, assuming Michaelis-Menton kinetics, and the data (inset) are the meanϮSEM obtained from the study of BBM preparations from kidneys obtained from five different rats in each group. For each point, uptake measurements were performed in triplicate. The graph presents representative results obtained for one rat from each group in a single experiment. Na-dependent SO 4 uptake was calculated by subtracting the uptake measured under Na 
(% control) Na-SO 4 min D-deficient with vitamin D-supplemented rats (Fig. 4) . It is noteworthy that the important increase in sulfate excretion contrasted with a modest decrease ‫ف(‬ 30%) of sulfate filtered load, due to the slight decreases of sulfatemia and glomerular filtration rate. Compatible with the lack of effect of calcium/ lactose supplementation on renal Na-SO 4 cotransport mRNA expression, protein abundance and activity, fractional sulfate excretion was not different comparing vitamin D-deficient animals that did or did not receive calcium/lactose supplementation (Fig. 4) .
Discussion
Inorganic sulfate is essential for a variety of metabolic processes, and sulfate requirements in man and other mammalian species appear to change as a function of growth and age (34) (35) (36) . Thus, mechanisms permitting the regulation of plasma sulfate levels are likely to be important for normal physiology, and abnormalities in these processes may contribute to the pathogenesis of various diseases. This study demonstrates for the first time that the expression and activity of the recently cloned renal sodium-sulfate cotransporter, renal sulfate handling, and serum sulfate concentrations are concomitantly regulated by vitamin D status. Plasma sulfate levels, renal Na-SO 4 cotransport expression, and renal sulfate handling were evaluated in vitamin D-deficient rats and in vitamin D-deficient animals rendered normocalcemic by either vitamin D or calcium/lactose supplementation. Vitamin D-deficient rats developed hyposulfatemia and decreased renal Na-SO 4 cotransport activity measured in BBM vesicles. This decrease in renal Na-SO 4 cotransport activity resulted from a decrease in the V max of the transport system, and was accompanied by parallel decreases in both Na-SO 4 cotransport protein and mRNA content. Furthermore, it was associated with an increase in the fractional excretion of sulfate, strongly suggesting that the changes in Na-SO 4 cotransporter activity directly influence renal sulfate excretion, and thereby contribute to the observed changes in plasma sulfate. It is noteworthy that the decrease in plasma sulfate was more moderate than might have been anticipated from the large increase in urinary sulfate excretion observed in vitamin D-depleted animals. These findings suggest that additional changes are occurring that partially compensate for the increased renal sulfate excretion in vitamin D-deficient animals. Modulation of intestinal absorption of sulfate could participate. Intestinal sulfate absorption depends, at least in part, on sodium-dependent transport, and the intestinal Na-SO 4 cotransporter is known to be the same as that expressed in the kidney (12, 13) . Whether vitamin D status also regulates the intestinal Na-SO 4 cotransporter remains to be determined. It is also possible that vitamin D deficiency results in increased sulfate release from bone. In this regard, no information is available concerning the regulation by vitamin D of the sulfate transport protein DTDST expressed in bone (4) . Clearly, definition of the relative contribution of renal sulfate excretion, intestinal absorption, and release from bone in modulating serum sulfate in vitamin D deficiency will require further study.
Vitamin D supplementation resulted in a return of both renal cortical Na-SO 4 cotransport mRNA and protein to normal levels, changes that were associated with a normalization of fractional sulfate excretion and correction of the hyposulfatemia. Prior studies have indicated that sex, menstrual cycle, pregnancy, and thyroid hormone can influence plasma SO 4 levels (1), but the mechanisms involved have not been defined. Regulation of renal BBM Na-SO 4 cotransport activity by glucocorticoids (37) and thyroid hormone has also been reported (38), although the latter finding was not confirmed in all studies (39) . In neither case, however, were changes in Na-SO 4 cotransport activity demonstrated to produce changes in renal sulfate handling or serum sulfate levels. In addition, changes in Na-SO 4 cotransport activity have not been shown previously to result from regulation of the expression of Na-SO 4 cotransport protein or mRNA, as demonstrated in this study.
Renal Na-SO 4 cotransport activity, protein abundance, and mRNA levels remained decreased, and fractional excretion of sulfate remained increased in vitamin D-deficient rats that received calcium/lactose supplementation. These rats had normal plasma calcium concentrations, but lower 1,25(OH) 2 Interestingly, sulfatemia was normal in vitamin D-deficient animals receiving lactose and calcium, despite that renal Na-SO 4 cotransport activity and expression remained decreased and fractional sulfate excretion remained increased in these animals. This implies that the renal transport of sulfate is still compromised in this group of animals as a consequence of the persistent vitamin D deficiency. These findings also indicate the restoration of plasma sulfate must have resulted from changes independent of renal sulfate transport, such as increased intestinal absorption of sulfate. As discussed above, changes in the activity of the intestinal Na-SO 4 cotransporter could potentially contribute to the regulation of serum sulfate. Alternatively, increased intestinal absorption of sulfate could occur in this group of rats by a mechanism independent of Na-SO 4 cotransport activity. In this regard, a lactose-induced enhancement of the passive (or diffusional) component of calcium transport has been suggested to explain the ability of lactose to increase intestinal calcium absorption (15, 16 ). An analogous mechanism might be responsible for increasing intestinal sulfate uptake, thereby increasing serum sulfate concentrations.
A deficit in sulfate occurring in vitamin D deficiency may have important clinical implications. Proteoglycans are extremely important for the maintenance of the normal structure and function of bone and cartilage. Sulfation of all naturally occurring sulfated compounds, including proteoglycans, depends on the availability of inorganic sulfate, which is the pre-cursor of 3Ј-phosphoadenosine 5Ј-phosphosulfate (PAPS), the activated form of sulfate (40) . Recently, several inherited forms of osteochondrodysplasia have been shown to result from abnormalities in sulfate transport or metabolism (4) (5) (6) . A limitation in the availability of inorganic SO 4 produced by an acquired defect may also result in abnormal sulfation of proteoglycans. Altered proteoglycan synthesis by aortic endothelial cells (41) and epiphyseal cartilage (42) maintained in vitro in medium containing low sulfate concentrations has been observed. Thus, by regulating renal sulfate transport and sulfatemia, vitamin D status would appear to be a major factor influencing the amount of inorganic sulfate available for sulfation of proteoglycans.
In conclusion, these results demonstrate that vitamin D status modulates renal Na-SO 4 sulfate cotransport and sulfate homeostasis, and thereby influences the amount of inorganic sulfate available for sulfation of proteoglycans. Therefore, vitamin D deficiency may result in a defect in the synthesis of these important matrix components, a mechanism that may contribute to producing some of the abnormalities observed in rickets and osteomalacia. As it has been demonstrated by in vitro studies that PTH can directly stimulate the sulfation of proteoglycans (43) , the regulation of sulfate metabolism, like that of calcium and phosphate, appears to be subject to coordinate regulation by both PTH and vitamin D.
